A randomized two-way crossover bioequivalence study in healthy adult volunteers of paediatric zidovudine/lamivudine/nevirapine fast-disintegrating fixed-dose combination tablet

OBJECTIVE: The bioequivalence study was conducted to compare the developed paediatric fixed-dose combination (FDC) zidovudine/lamivudine/nevirapine (60/30/50 mg) tablet – the test formulation – with the combined mixture of single-entity innovator products (reference product). METHODS: A single-dose...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pharm Pharmacol
Autores principales: Joshi, Anjali, Gbadero, Daniel, Esseku, Fredrick, Adesanya, Olufikayo J, Adeyeye, Moji C
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938945/
https://ncbi.nlm.nih.gov/pubmed/27859251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jphp.12666
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares